HK1212028A1 - Methods and diets to protect against chemotoxicity and age related illnesses - Google Patents
Methods and diets to protect against chemotoxicity and age related illnessesInfo
- Publication number
- HK1212028A1 HK1212028A1 HK15112774.0A HK15112774A HK1212028A1 HK 1212028 A1 HK1212028 A1 HK 1212028A1 HK 15112774 A HK15112774 A HK 15112774A HK 1212028 A1 HK1212028 A1 HK 1212028A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- diets
- methods
- protect against
- age related
- related illnesses
- Prior art date
Links
- 235000005911 diet Nutrition 0.000 title 1
- 230000037213 diet Effects 0.000 title 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/115—Fatty acids or derivatives thereof; Fats or oils
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/15—Vitamins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/15—Vitamins
- A23L33/155—Vitamins A or D
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/30—Dietetic or nutritional methods, e.g. for losing weight
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
- A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/401—Proline; Derivatives thereof, e.g. captopril
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/02—Nutrients, e.g. vitamins, minerals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/02—Antidotes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/205—Amine addition salts of organic acids; Inner quaternary ammonium salts, e.g. betaine, carnitine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
- A61K31/23—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/404—Indoles, e.g. pindolol
- A61K31/405—Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4172—Imidazole-alkanecarboxylic acids, e.g. histidine
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Food Science & Technology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Nutrition Science (AREA)
- Mycology (AREA)
- Polymers & Plastics (AREA)
- Epidemiology (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Molecular Biology (AREA)
- Immunology (AREA)
- Biomedical Technology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Diabetes (AREA)
- Organic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Microbiology (AREA)
- Pathology (AREA)
- General Physics & Mathematics (AREA)
- Biotechnology (AREA)
- Cell Biology (AREA)
- Biochemistry (AREA)
- Analytical Chemistry (AREA)
- Pediatric Medicine (AREA)
- Physics & Mathematics (AREA)
- Obesity (AREA)
- Emergency Medicine (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Toxicology (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201361763797P | 2013-02-12 | 2013-02-12 | |
PCT/US2014/016025 WO2014127000A2 (en) | 2013-02-12 | 2014-02-12 | Methods and diets to protect against chemotoxicity and age related illnesses |
Publications (1)
Publication Number | Publication Date |
---|---|
HK1212028A1 true HK1212028A1 (en) | 2016-06-03 |
Family
ID=51297596
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK15112774.0A HK1212028A1 (en) | 2013-02-12 | 2015-12-29 | Methods and diets to protect against chemotoxicity and age related illnesses |
Country Status (13)
Country | Link |
---|---|
US (3) | US9237761B2 (xx) |
EP (2) | EP3510875B1 (xx) |
JP (2) | JP6885671B2 (xx) |
KR (1) | KR20150124962A (xx) |
CN (3) | CN109187991B (xx) |
AU (3) | AU2014216349B2 (xx) |
BR (1) | BR112015019223A2 (xx) |
CA (1) | CA2900782C (xx) |
ES (1) | ES2807781T3 (xx) |
HK (1) | HK1212028A1 (xx) |
MX (1) | MX2015010320A (xx) |
RU (2) | RU2674681C2 (xx) |
WO (1) | WO2014127000A2 (xx) |
Families Citing this family (28)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US10015980B2 (en) | 2012-10-22 | 2018-07-10 | University Of Southern California | Methods and formulations promoting tissue/organ regeneration, longevity and healthspan |
BR112015019223A2 (pt) * | 2013-02-12 | 2017-07-18 | Univ Southern California | método para prolongar a longevidade de um indivíduo; método para diminuir os níveis de glicose e/ou igf-1 em um indivíduo; método para aliviar um sintoma de quimiotoxicidade em um indivíduo; e método para tratar a quimiotoxicidade em um indivíduo |
EP3915399A1 (en) | 2013-07-01 | 2021-12-01 | University of Southern California | Fasting condition as dietary treatment of diabetes |
US10172839B2 (en) | 2014-03-06 | 2019-01-08 | University Of Southern California | Use of short term starvation regimen in combination with kinase inhibitors to enhance traditional chemo-drug efficacy and feasibility and reverse side effects of kinases in normal cells and tissues |
AU2015240720B2 (en) | 2014-04-02 | 2019-12-05 | University Of Southern California | Autoimmunity and multiple sclerosis treatment |
EP3256465B1 (en) | 2015-02-12 | 2021-04-07 | University of Southern California | Blockers of the growth hormone receptor in disease prevention and treatment |
BR112017022244A2 (pt) * | 2015-04-16 | 2018-07-10 | Univ Southern California | métodos para tratar uma hiperglicemia em um indivíduo submetido à quimioterapia, método para tratar uma hiperglicemia em um indivíduo submetido à quimioterapia ou outra terapia de câncer, método para substituir ou aprimorar um efeito de uma dieta que mimetiza jejum em sensibilização de célula cancerígena, e método |
EP3291693A4 (en) * | 2015-05-06 | 2019-04-03 | University of Southern California | FASTENIMITIER AND IMPROVING DIET FOR THE TREATMENT OF HYPERTENSION AND LIPID DISORDER |
WO2017097865A1 (en) * | 2015-12-07 | 2017-06-15 | Istituto Europeo Di Oncologia | Combination of caloric restriction (cr) or igf1/insulin receptor inhibitor with lsd1 inhibitor |
JP2019504073A (ja) * | 2016-01-12 | 2019-02-14 | ユニバーシティ オブ サザン カリフォルニア | 多発性骨髄腫及び他のがんに対する食事療法としての長期断食模倣の使用 |
ES2970314T3 (es) | 2016-02-15 | 2024-05-28 | Univ Southern California | Combinaciones de fármacos y métodos para estimular una regeneración similar a la embrionaria para tratar la diabetes |
US11540550B2 (en) * | 2016-05-11 | 2023-01-03 | University Of Southern California | Fasting mimicking diet (FMD) as an immunoregulatory treatment for gastrointestinal autoimmune/inflammatory diseases |
IT201700008499A1 (it) * | 2017-01-26 | 2018-07-26 | Univ Degli Studi Genova | Composizione dietetica per la prevenzione e/o il trattamento dell’iperplasia dell’endometrio |
US11284640B2 (en) * | 2017-02-14 | 2022-03-29 | University Of Southern California | Fasting mimicking diet |
JP7364170B2 (ja) | 2018-03-15 | 2023-10-18 | ユニバーシティ オブ サザン カリフォルニア | 水のみの絶食ではない断食模倣食(fmd)は炎症及びibd病状からの回復を促進する |
AU2019280170B2 (en) * | 2018-06-07 | 2024-03-28 | Société des Produits Nestlé S.A. | Methods and compositions for increasing ketone bodies in animals |
DE212018000421U1 (de) | 2018-07-18 | 2021-03-01 | Andreas Michalsen | Auswirkungen einer kurzzeitigen Diät, die Fasten imitiert, auf die Lebensqualität und die Verträglichkeit einer Chemotherapie bei Patientinnen mit Krebs |
CN111000217A (zh) * | 2018-10-04 | 2020-04-14 | 株式会社明治 | 难治性癌症的饮食疗法及适用于其的治疗饮食 |
KR20210113161A (ko) | 2018-11-09 | 2021-09-15 | 엘-뉴트라 인코포레이티드 | 간헐적 단식-모방을 위한 영양 바 |
JP2022530671A (ja) * | 2019-04-30 | 2022-06-30 | ユニバーシティ オブ サザン カリフォルニア | アルツハイマー病(ad)の介入のための断食模倣食(fmd) |
CN112273641A (zh) * | 2019-07-23 | 2021-01-29 | 中国科学院上海营养与健康研究所 | 一种非节食性的高低蛋白食物交替使用有效干预糖尿病的方法 |
WO2021126968A1 (en) * | 2019-12-16 | 2021-06-24 | University Of Southern California | Utilization of a fasting-mimicking diet to reduce senescent cells and inflammation |
US20230000888A1 (en) | 2019-12-19 | 2023-01-05 | Leibniz-Institut Für Alternsforschung - Fritz-Lipmann-Institut E.V. (Fli) | Nad-precursors and dietary restriction for treating age related medical conditions |
IT202000008740A1 (it) * | 2020-04-23 | 2021-10-23 | L Nutra Inc | Composizione dietetica per l’incremento della massa magra e della massa muscolare |
IT202000016957A1 (it) | 2020-07-13 | 2022-01-13 | Univ Degli Studi Di Palermo | Composizione dietetica per il trattamento della depressione |
CN114631629A (zh) * | 2020-12-15 | 2022-06-17 | 中国科学院上海营养与健康研究所 | 一种低蛋白治疗肥胖的方法 |
CN114631628A (zh) * | 2020-12-15 | 2022-06-17 | 中国科学院上海营养与健康研究所 | 一种增加血液fgf21浓度的方法 |
WO2024044036A1 (en) * | 2022-08-23 | 2024-02-29 | University Of Southern California | Dietary compositions to extend longevity while maximizing strength and function |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6406853B1 (en) * | 1999-12-23 | 2002-06-18 | The Regents Of The University Of California | Interventions to mimic the effects of calorie restriction |
KR20040026665A (ko) * | 2001-06-15 | 2004-03-31 | 인터레우킨 제네틱스, 인코포레이티드 | 노화 관련 증상의 조기 개시를 검출 및 치료하는 방법 |
US20050031671A1 (en) * | 2003-08-06 | 2005-02-10 | James Johnson | Weight management, longevity and health paradigm |
BRPI0519507A2 (pt) * | 2004-12-27 | 2009-03-10 | Nestec Sa | uso de fàrmula lactente com teor de proteÍna reduzido |
CA2637329A1 (en) * | 2006-02-01 | 2007-08-09 | Nestec S.A. | Nutritional system and methods for increasing longevity |
JP2011523626A (ja) * | 2008-04-24 | 2011-08-18 | ユニバーシティー オブ サウザン カリフォルニア,ユーエスシー スティーブンズ | 化学療法、放射線療法、酸化ストレス、および加齢を防御するための食事組成物ならびに方法 |
CN101385543A (zh) * | 2008-10-23 | 2009-03-18 | 上海交通大学 | 低蛋白食品及其制备方法 |
EP2490684B1 (en) * | 2009-10-22 | 2018-01-03 | University Of Southern California | Methods and nutritional formulations to increase the efficacy and reduce the side effects of cancer treatment |
US10015980B2 (en) * | 2012-10-22 | 2018-07-10 | University Of Southern California | Methods and formulations promoting tissue/organ regeneration, longevity and healthspan |
BR112015019223A2 (pt) * | 2013-02-12 | 2017-07-18 | Univ Southern California | método para prolongar a longevidade de um indivíduo; método para diminuir os níveis de glicose e/ou igf-1 em um indivíduo; método para aliviar um sintoma de quimiotoxicidade em um indivíduo; e método para tratar a quimiotoxicidade em um indivíduo |
-
2014
- 2014-02-12 BR BR112015019223A patent/BR112015019223A2/pt not_active Application Discontinuation
- 2014-02-12 RU RU2015134780A patent/RU2674681C2/ru active
- 2014-02-12 ES ES19160815T patent/ES2807781T3/es active Active
- 2014-02-12 US US14/178,953 patent/US9237761B2/en active Active
- 2014-02-12 CN CN201811023405.1A patent/CN109187991B/zh active Active
- 2014-02-12 CA CA2900782A patent/CA2900782C/en active Active
- 2014-02-12 EP EP19160815.7A patent/EP3510875B1/en active Active
- 2014-02-12 JP JP2015557219A patent/JP6885671B2/ja active Active
- 2014-02-12 EP EP14751117.4A patent/EP2956776A4/en not_active Ceased
- 2014-02-12 CN CN201480008545.5A patent/CN105008929B/zh active Active
- 2014-02-12 WO PCT/US2014/016025 patent/WO2014127000A2/en active Application Filing
- 2014-02-12 AU AU2014216349A patent/AU2014216349B2/en active Active
- 2014-02-12 KR KR1020157024630A patent/KR20150124962A/ko not_active IP Right Cessation
- 2014-02-12 RU RU2018141475A patent/RU2018141475A/ru unknown
- 2014-02-12 CN CN202111523134.8A patent/CN114236130A/zh active Pending
- 2014-02-12 MX MX2015010320A patent/MX2015010320A/es unknown
-
2015
- 2015-12-29 HK HK15112774.0A patent/HK1212028A1/xx not_active IP Right Cessation
-
2016
- 2016-01-15 US US14/996,946 patent/US20160331016A1/en active Pending
- 2016-10-20 US US15/298,963 patent/US20170035094A1/en not_active Abandoned
-
2019
- 2019-09-30 JP JP2019179570A patent/JP2020073473A/ja active Pending
-
2020
- 2020-01-15 AU AU2020200297A patent/AU2020200297B2/en active Active
-
2022
- 2022-04-27 AU AU2022202764A patent/AU2022202764A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
EP2956776A4 (en) | 2016-12-21 |
JP2016509994A (ja) | 2016-04-04 |
EP3510875B1 (en) | 2020-06-10 |
AU2020200297A1 (en) | 2020-02-06 |
ES2807781T3 (es) | 2021-02-24 |
JP6885671B2 (ja) | 2021-06-16 |
EP2956776A2 (en) | 2015-12-23 |
CN109187991A (zh) | 2019-01-11 |
US20160331016A1 (en) | 2016-11-17 |
AU2022202764A1 (en) | 2022-05-19 |
CN105008929A (zh) | 2015-10-28 |
AU2014216349B2 (en) | 2019-10-24 |
AU2020200297B2 (en) | 2022-04-07 |
WO2014127000A2 (en) | 2014-08-21 |
US20170035094A1 (en) | 2017-02-09 |
JP2020073473A (ja) | 2020-05-14 |
CN105008929B (zh) | 2018-10-02 |
BR112015019223A2 (pt) | 2017-07-18 |
CN114236130A (zh) | 2022-03-25 |
EP3510875A1 (en) | 2019-07-17 |
CA2900782C (en) | 2022-09-27 |
KR20150124962A (ko) | 2015-11-06 |
RU2674681C2 (ru) | 2018-12-12 |
US20140227373A1 (en) | 2014-08-14 |
MX2015010320A (es) | 2016-06-02 |
RU2018141475A (ru) | 2019-03-21 |
US9237761B2 (en) | 2016-01-19 |
RU2015134780A (ru) | 2017-03-20 |
RU2018141475A3 (xx) | 2022-03-29 |
AU2014216349A1 (en) | 2015-08-06 |
CN109187991B (zh) | 2021-12-24 |
CA2900782A1 (en) | 2014-08-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1212028A1 (en) | Methods and diets to protect against chemotoxicity and age related illnesses | |
IL240518A0 (en) | Capsule for single use and system | |
HK1219947A1 (zh) | 抑製劑及其用途 | |
IL241512A0 (en) | Pharmaceutical preparations containing glycosidase inhibitors and their preparation | |
HRP20180635T1 (hr) | Pirazolamidni spoj i njegova upotreba u medicini | |
EP3031353C0 (en) | ORAL CARE SYSTEM AND PROCEDURES | |
HK1221721A1 (zh) | 蛋白抑制性的改性的二氫喹喔啉酮類化合物和二氫吡啶並吡嗪酮類化合物 | |
GB201305277D0 (en) | Novel combination and use | |
ZA201604695B (en) | Oral care compositions and methods | |
PL3029038T3 (pl) | Związek tetrazolinonowy i jego zastosowanie | |
ZA201601795B (en) | Oral care implement and oral care system | |
IL245820A0 (en) | Compositions and methods for oral care | |
EP3022320A4 (en) | Whole-genome and targeted haplotype reconstruction | |
IL244214B (en) | Thienopiperidine derivative and its use | |
EP2862480A4 (en) | CHAIR FOR THE PROTECTION OF SPINE AND HIP | |
IL245597A0 (en) | Anti-neuroinflammatory and protective compounds in Achillea fragrantissima - implications for inflammatory and neurodegenerative diseases | |
ZA201604303B (en) | Oral care compositions and methods | |
PL3055307T3 (pl) | Podstawione berbiny i ich synteza | |
HK1219233A1 (zh) | 美羅培南衍生物及其用途 | |
ZA201604306B (en) | Oral care compositions and methods | |
IL240177A0 (en) | Converted chromium-6-yloxy-cycloalkanes and their use as drugs | |
ZA201504080B (en) | Combination medicament comprising phenylephrine and paracetamol | |
GB201309498D0 (en) | Novel diagnosis and therapy | |
TWM475170U (en) | Headgear and scarf structure | |
GB201301393D0 (en) | Kiddibidet and pottibidet |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PC | Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee) |
Effective date: 20230217 |